International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s): 320

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, metronidazole, anti-infective agent, antibiotic, antibacterial agent, antiprotozoal agent, antimicrobial agent

Related Categories: FORMULATIONS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 320
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A	Jan/Feb 2003 Pg. 10-15 View Sample
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Riepl Mike	Mar/Apr 2022 Pg. 94-98
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary	Nov/Dec 2008 Pg. 558-564
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents Allen Loyd V Jr	May/Jun 2020 Pg. 206-212
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion Allen Loyd V Jr	May/Jun 2022 Pg. 238
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension McElhiney Linda F	Jan/Feb 2021 Pg. 24-28
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Riepl Mike	Jul/Aug 2022 Pg. 270-274
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James	Jan/Feb 2020 Pg. 77-82
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Riepl Mike	Nov/Dec 2022 Pg. 480-488
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Allen Loyd V Jr	Jan/Feb 2020 Pg. 38-43
Basics of Sterile Compounding: Excipients Used in Injections Akers Michael J	Jul/Aug 2017 Pg. 301-308
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G	Nov/Dec 2019 Pg. 504-510
Acidifying Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 1999 Pg. 309-310
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 508
Return to Top